Key Takeaways
- • Delphinus Venture Capital, an Aarhus-based evergreen fund capitalized at €80 million (approximately DKK 600 million), has launched with backing from Aarhus University Research Foundation, HEARTLAND, Norlys, and the Salling Group to support research-driven startups across East and Central Jutland.
- • The fund operates with a long-term investment horizon across pre-seed through scale-up stages, differentiated from traditional venture models by its structural flexibility and commitment to value creation over quick returns, with no predetermined exit timeline.
- • Mathias Brink Lorenz, formerly Investment Director at the European Circular Bioeconomy Fund in Germany, has been appointed CEO and brings international venture capital experience to lead deployment strategy.
- • Delphinus prioritizes startups emerging from research institutions, including Aarhus University, Aarhus University Hospital, and regional innovation hubs, positioning itself as a bridge between academic innovation and commercialization.
- • The evergreen fund structure enables participation from early-stage development through late-stage growth, allowing flexibility in capital deployment and longer-term support for portfolio companies building global solutions.
Summary
Delphinus Venture Capital has officially launched as an €80 million evergreen venture fund headquartered in Aarhus, Denmark, established through a strategic partnership between the Aarhus University Research Foundation and three regional anchor investors: HEARTLAND, Norlys, and the Salling Group. The initiative represents a coordinated effort to strengthen the startup ecosystem across East and Central Jutland by channeling institutional capital toward research-intensive ventures with global potential.
The fund's structural design reflects a deliberate departure from traditional venture capital models. Rather than operating under fixed fund lifecycles with predetermined exit windows, Delphinus is configured as an evergreen vehicle, enabling long-term capital commitment and flexibility in investment timing and strategy. This approach allows the fund to participate from pre-seed and early-stage investments through late-stage growth rounds, accommodating the extended development timelines typical of deep-tech and research-driven companies.
Delphinus will concentrate on startups originating from research environments, particularly those emerging from Aarhus University, Aarhus University Hospital, and connected regional research and innovation hubs. The fund's name references the dolphin depicted on Aarhus University's seal, symbolizing the intellectual connection between the institution and the investment vehicle. According to CEO Mathias Brink Lorenz, the fund's deliberate design enables "long-term commitment and flexibility in our investments" to create meaningful value for portfolio companies transforming research into scalable global solutions. Lorenz brings credibility to the role through prior service as Investment Director at the European Circular Bioeconomy Fund, an institutional investor in the specialized bioeconomy sector.
The fund's positioning reflects broader European interest in translating academic research into commercially viable enterprises, with Delphinus explicitly designed to bridge the gap between discovery and market-scale innovation. By maintaining close geographic and institutional proximity to research facilities while deploying substantial capital, the fund aims to support entrepreneurs in converting research-backed ideas into products and services with international reach.
The fund's structural design reflects a deliberate departure from traditional venture capital models. Rather than operating under fixed fund lifecycles with predetermined exit windows, Delphinus is configured as an evergreen vehicle, enabling long-term capital commitment and flexibility in investment timing and strategy. This approach allows the fund to participate from pre-seed and early-stage investments through late-stage growth rounds, accommodating the extended development timelines typical of deep-tech and research-driven companies.
Delphinus will concentrate on startups originating from research environments, particularly those emerging from Aarhus University, Aarhus University Hospital, and connected regional research and innovation hubs. The fund's name references the dolphin depicted on Aarhus University's seal, symbolizing the intellectual connection between the institution and the investment vehicle. According to CEO Mathias Brink Lorenz, the fund's deliberate design enables "long-term commitment and flexibility in our investments" to create meaningful value for portfolio companies transforming research into scalable global solutions. Lorenz brings credibility to the role through prior service as Investment Director at the European Circular Bioeconomy Fund, an institutional investor in the specialized bioeconomy sector.
The fund's positioning reflects broader European interest in translating academic research into commercially viable enterprises, with Delphinus explicitly designed to bridge the gap between discovery and market-scale innovation. By maintaining close geographic and institutional proximity to research facilities while deploying substantial capital, the fund aims to support entrepreneurs in converting research-backed ideas into products and services with international reach.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.